Expression of epithelial-cadherin, CD44v6 and connexin43 in hepatocellular carcinoma

Chinese Journal of Pathology

Volumn 35, Issue 10, 2006, Pages 616-619

  Zhang, Bao Yan ^a   Dai, Xiao Wen ^b   Chen, Qing Yong ^b   Fang, Li ^b   Qian, Bin ^b   Sun, Guo Ying ^b   Cui, Hai Hong ^b  

^a The 117th Hospital of Chinese PLA   (China)

^b NONE

Author keywords

Carcinoma, hepatocellular; Connexins; Fluorescent antibody technique; Microscopy, confocal

Indexed keywords

CADHERIN; CD44V6 ANTIGEN; CONNEXIN 43;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LASER MICROSCOPY; LIVER CELL CARCINOMA; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD44; CADHERINS; CARCINOMA, HEPATOCELLULAR; CONNEXIN 43; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PROGNOSIS;

EID: 33845197507     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Vos CBJ, Cleton-Jansen AM, Berx G, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer, 1997,76:1131-1133.
2. Kozyraki R, Scoazer JY, Flejou JF, et al. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology, 1996,110:1137-1149.
3. Jiao W, Miyazaki K, Kitajima Y. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer, 2002,86;98-101.
4. Wei Y, Van Nhieu JT, Prigent S, et al. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology, 2002,36:692-701.
5. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol, 2003,4: 33-45.
6. Endo K, Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol, 2000,32:78-84.
7. Su YA, Bittner ML, Chen Y, et al. Identification of tumor suppressor genes using human melanoma cell lines UACC903, UACC903(+ 6), and SRS3 by comparison of expression profiles. Mol Carcinog,2000, 28:119-127.
8. Krutovskikh VA, Troyanovsky SM, Piccoli C, et al. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene, 2000,19:505-513.